However, current clinical therapy for Topo II or Hsp90 alone is not ideal, and combined drug research shows that Topo II poisons and Hsp90 inhibitors have a synergistic effect in tumor treatment [20,21,22]. The gene discussed is HSP90AA1; the disease is neoplasm.